Head & Neck/Thyroid Cancers
News
Most thyroid nodules have favorable prognosis
Key clinical point: The vast majority of thyroid nodules found to be benign at baseline remained so 5 years later. Major finding: Cancer arose in...
Conference Coverage
Teamwork key to head and neck cancer management
New Therapies
Rising to the therapeutic challenge of head and neck cancer
News
Lenvatinib extends PFS significantly in iodine-refractory relapsed thyroid cancer
News
Lenvima gets the FDA’s nod for differentiated thyroid cancer
David Henry's JCSO Podcast
David Henry's JCSO podcast, January 2015
Original Report
Impact of a telehealth intervention on quality of life and symptom distress in patients with head and neck cancer
Original Report
Beneficial effects of animal-assisted visits on quality of life during multimodal radiation-chemotherapy regimens
News
Sunitinib elicits “exceptional” response in refractory thymic carcinoma
Key clinical point: The oral tyrosine kinase inhibitor sunitinib shows “exceptional” activity against thymic carcinoma. Major finding: 21 of the...
News
Study aims to determine prognostic factors for subset of thyroid cancer patients
Key clinical point: Radioactive iodine–refractory differentiated thyroid cancer patients with no progressive disease and a tumor size of less than...
News
Postdiagnosis imaging increasing for patients with all stages of thyroid cancer
Key clinical point: Increased imaging may identify low-volume recurrent disease that is unlikely to be clinically significant, leading to...